Open access
Sep 2026
Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study.
In this open-label, proof-of-concept study, empagliflozin was associated with improved short-term natriuretic indices over 10 days in diabetic patients with decompensated cirrhosis and refractory ascites, without serious adverse events.
Rong-Ya Shi, Yuan Gao, Yun-Yi Gao et al.
· Journal of Gastrointestinal... · 0 citations